@article{Siren1982, author = {Sir{\´e}n, Anna-Leena}, title = {Differences in central actions of arachidonic acid and prostaglandin F\(_{2\alpha}\) between spontaneously hypertensive and normotensive rats}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-63324}, year = {1982}, abstract = {Prostag1andin F\(_{2\alpha}\) (PGF\(_{2\alpha}\)) is one of the most common metabo1ites of arachidonic acid (M) in rat brain. When administered intracerebroventricularly (i.c.v.) to rats, both AA and PGFal exert dose-related hypertensive, tachycardic and hyperthermic effects. Metabolie alterations in the endogenaus formation of some prostaglandins in the brain-stem of spontaneously hypertensive rats (SHR) have been reported. Therefore the central effects of AA and PGF \(_{2\alpha}\) on blood pressure, heart rate and body temperature were studied both in SHR and nonootensive Wistar rats (NR) under urethane-anaesthesia. The hypertensive effect of AA i.c.v. (0.01-100 \(\mu\)g/rat) was larger in magni tude in SHR than in NR, but there was no significant difference in the M-induced changes of heart rate and body temperature between the groups. Pretreatment of NR wi th soditm1 :meclofenamate (1 mg/rat i.c.v.) antagonised the central effects of M indicating that these effects are not due to M itself but to its conversion to prostaglandins. Unlike the effects of AA, the central hypertensive, tachycardic and hyperthennic responses to PGF\(_{2\alpha}\) (0.5-50 l-lg/rat i.c.v .) were significantly attenuated in SHR. The present results obtained with M are conpatible with the previous assumption that the synthesis of prostaglandins in the brain of SHR might differ from that in NR. The results also demonstrate that the central effects of PGF\(_{2\alpha}\) are reduced in SHR.}, subject = {Neurobiologie}, language = {en} } @article{EimerlSirenFeuerstein1986, author = {Eimerl, J. and Sir{\´e}n, Anna-Leena and Feuerstein, G.}, title = {Systemic and regional hemodynamic effects of leukotrienes D\(_4\) and E\(_4\) in the conscious rat}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-63317}, year = {1986}, abstract = {No abstract available}, subject = {Neurobiologie}, language = {en} } @article{SirenFeuersteinLabrooetal.1986, author = {Sir{\´e}n, Anna-Leena and Feuerstein, G. and Labroo, V. M. and Coleen, L. A. and Lozovsky, D.}, title = {Effect of thyrotropin releasing hormone and some of its histidine analogs on the cardiovascular system and prolactin release in the conscious rat}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-63307}, year = {1986}, abstract = {The cardiovascular and endocrine activity of three analogs of thyrotropin releasing hor.mone (TRH), 4-nitro-imidazole TRH (4-nitroTRH), 2-trifluoro-methyl-imidazole TRH (2-TFM-TRH) and 4-trifluoromethyl- imidazole TRH (4-TFM-TRH), was compared to TRH in conscious rats. Injection of TRH or the three analogs (1 mg/kg or 5 mg/kg) into the arterial line induced increases in mean arterial pressure, pulse pressure and heart rate and raised plasma prolactin (PRL). None of the analogs were more potent than TRH in inducing cardiovascular changes. The 4-TFM-TRH was significantly less potent than the 2-TFM-TRH in increasing blood pressure, while the nitro-TRH was more potent than the 2-TFM-TRH in producing tachycardia. TRH induced a two-fold increase in PRL at the 5 mg/kg dose, while both the fluorinated analogs elici ted a 4 to 5 fold increase in PRL at the higher dose. The present results suggest that the receptors for TRH-elicited PRL release differ from TRH-receptors involved in its cardiovascular actions.}, subject = {Neurobiologie}, language = {en} } @article{SirenFeuerstein1986, author = {Sir{\´e}n, Anna-Leena and Feuerstein, G.}, title = {Effect of T-2 toxin on regional blood flow and vascular resistance in the conscious rat}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-63293}, year = {1986}, abstract = {The acute effect ofT-2 toxemia on local blood flow and vascular resistance in hindquarter. mesenteric. and renal vascular beds was continuously measured by the directional pulsed Doppler technique in conscious, male Sprague-Dawley rats. Intravenous injection ofT-2 toxin (I mg/kg) in the conscious rat reduced blood flow and increased vascular resistance in all blood vessels studied but had no significant effect on mean arterial pressure or heart rate. The blood flow in hindquarters gradually decreased to a minimum of -77 ± 9\% (mean ±SE) 6 hr after the toxin injection. The hindquarter vascular resistance concomitantly increased to a maximum value of + 323 ± 69\% above thc resistance before toxin administration. Mesenteric and renal blood flow initially increased (slightly) and then gradually decreased. The maximum drop of blood flow, -90 ± 13\% and -76 ± 13\% for the mesenteric and renal vascular beds, respectively, was achieved 4 hr after T-2 toxin injection and the blood flow values remained low for up to 6 hr. Simultaneously with the impairment of}, subject = {Neurobiologie}, language = {en} } @article{SirenPowellFeuerstein1986, author = {Sir{\´e}n, Anna-Leena and Powell, E. and Feuerstein, G.}, title = {Thyrotropin releasing hormone in hypovolemia: a hemodynamic evaluation in the rat}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-63288}, year = {1986}, abstract = {ln the present study the effects of thyrotropin releasing hormone (TRH) and its stable analogue, CG3703, on cardiac output (thermodilution, Cardiomax) and regional blood flow (BF; directional pulsed Doppler technique) were investigated in hypovolemic hypotension in the rat. In urethan-anesthetized rats TRH (0.5 or 2 mg/ kg ia) or CG3703 (0.05 or 0.5 mg/kg ia) reversed the bleeding (27\% of the blood volume)-induced decreases in mean arterial ...}, subject = {Neurobiologie}, language = {en} } @article{PaakkariNurminenSiren1986, author = {Paakkari, I. and Nurminen, M-L. and Sir{\´e}n, Anna-Leena}, title = {Cardioventilatory effects of TRH in anesthetized rats: role of the brainstem}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-63277}, year = {1986}, abstract = {Cardioventilator responses were studied in anaesthetized rats after injections of TRH into either the lateral (i.c.v. lat) or the fourth (i.c.v. IV) cerebral ventricles. TRH induced a morerapid hypertensive effect i.c.v. IV than i.c.v. lat. Blocking of the cerebral aqueduct abolished the hypertensive and tachypnoeic effects of TRH i.c.v. lat but not those of TRH i.c.v. IV. It is concluded that TRH increased blood pressure and ventilation rate via brain stem structures close to the fourtli ventricle.}, subject = {Neurobiologie}, language = {en} } @misc{FeuersteinSiren1987, author = {Feuerstein, G. and Sir{\´e}n, Anna-Leena}, title = {Opioid peptides: A role in hypertension? [Brief Review]}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-63262}, year = {1987}, abstract = {This review is an attempt to highlight evidence that may implicate the endogenaus opioid system in the pathogenesis of hypertension in humans. The evidence raised includes biochemical, physiological, pharmacological, and behavioral studies con~ucted in in vitro andin vivo systems, experimental models of hypertension, and hornans with essential hypertension. While the compelling biochemical and pharmacological evidence in experimental animals clearly shows the presence of opioid peptides and their receptors in strategic sites of cardiovascular control and potent cardiovascular response to opioid peptides, opioid antagonists show no consistent blockade or reversal of hypertension in experimental animals or humans. One possible explanation for this phenomenon could be the vast redundancy in systems regulating blood pressure (i.e., the blockade ofone system stillleaves many other systerils fully able to rapidly offset the eliminated system). Regarding the opioid system, the situation is much more complex, since some opioid receptors (\(\mu\)-type) niediate pressor responses, while other receptors (\(\kappa\)type) mediate depressor responses. Therefore, nonselective opioid receptor antagonists (e.g., naloxone), which block both types ofreceptors, can be devoid ofany cardiovascular activity, while a selective \(\mu\)-receptor antagonist or a selective arid potent \(\kappa\)-receptor agonist may produce the desired antihypertensive elfect. A combination of both actions (i.e., a drug that is both \(\mu\)antagonist and a \(\kappa\)antagonist) might be even more advantageous. Until such compounds are developed, this hypothesis will be hard to prove.}, subject = {Neurobiologie}, language = {en} } @article{LabrooCohenLozovskyetal.1987, author = {Labroo, V. M. and Cohen, L. A. and Lozovsky, D. and Sir{\´e}n, Anna-Leena and Feuerstein, G.}, title = {Dissociation of the cardiovascular and prolactin-releasing activities of TRH by histidine replacement}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-63253}, year = {1987}, abstract = {No abstract available}, subject = {Neurobiologie}, language = {en} } @article{FeuersteinLeaderSirenetal.1987, author = {Feuerstein, G. and Leader, P. and Sir{\´e}n, Anna-Leena and Braquet, P.}, title = {Protective effect of PAF-acether antagonist, BN 52021, in trichothecen toxicosis}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-63244}, year = {1987}, abstract = {Trichothecenes are mycotoxins which produce Iethai toxicosis in humans and animals, yet no adequate therapeutic regimen has been developed. This study provides evidence that the selective platelet activating factor (PAF) antagonist, BN 52021 (5-15 mg/kg i.v.) can prolong the survival of conscious rats exposed to a highly Iethai T -2 toxicosis. These data also suggest that P AF is an important mediator of this unique toxicosis.}, subject = {Neurobiologie}, language = {en} } @article{SirenFeuerstein1988, author = {Sir{\´e}n, Anna-Leena and Feuerstein, G.}, title = {Cardiovascular effects of rat calcitonin gene-related peptide in the conscious rat}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-63236}, year = {1988}, subject = {Neurobiologie}, language = {en} }